[go: up one dir, main page]

AR011115A1 - Compuestos sustituidos con sulfonamida, empleos para la preparacion de un medicamento y agente curativo - Google Patents

Compuestos sustituidos con sulfonamida, empleos para la preparacion de un medicamento y agente curativo

Info

Publication number
AR011115A1
AR011115A1 ARP980100549A ARP980100549A AR011115A1 AR 011115 A1 AR011115 A1 AR 011115A1 AR P980100549 A ARP980100549 A AR P980100549A AR P980100549 A ARP980100549 A AR P980100549A AR 011115 A1 AR011115 A1 AR 011115A1
Authority
AR
Argentina
Prior art keywords
preparation
substituted compounds
healing agent
sulfonamide
jobs
Prior art date
Application number
ARP980100549A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of AR011115A1 publication Critical patent/AR011115A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Compuestos sustituidos con sulfonamida de la formula (I), en donde R(1) a R(8) y X tienen los significados indicados en la reivindicaciones, son valiosospara la preparacion de medicamentos con un efecto bloqueante del canal de K+; en particular,para la preparacion de un medicamento para el tratamiento o laprofilaxis de la secrecion estimulada de ácidos gástricos; de ulceras del estomago y de la zona intestinal; de la esofaguitis de reflujo; de la diarrea;de todos los tipos de arritmias incluidas arritmias ventriculares y supraventriculares; y de arritmias de re-entrada y para la profilaxis de lamuerte repentina por parálisis cardíaca como consecuencia de la fibrilacion ventricular. Describe los empleos de los mismos para la preparacion de unmedicamento y un agente curativo.
ARP980100549A 1997-02-11 1998-02-09 Compuestos sustituidos con sulfonamida, empleos para la preparacion de un medicamento y agente curativo AR011115A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19705133A DE19705133A1 (de) 1997-02-11 1997-02-11 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
AR011115A1 true AR011115A1 (es) 2000-08-02

Family

ID=7819888

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100549A AR011115A1 (es) 1997-02-11 1998-02-09 Compuestos sustituidos con sulfonamida, empleos para la preparacion de un medicamento y agente curativo

Country Status (22)

Country Link
US (1) US6087399A (es)
EP (1) EP0857724A1 (es)
JP (1) JPH10218855A (es)
KR (1) KR19980071212A (es)
CN (1) CN1193012A (es)
AR (1) AR011115A1 (es)
AU (1) AU727216B2 (es)
BR (1) BR9800596A (es)
CA (1) CA2227930A1 (es)
CZ (1) CZ38598A3 (es)
DE (1) DE19705133A1 (es)
HR (1) HRP980066B1 (es)
HU (1) HUP9800277A3 (es)
ID (1) ID21266A (es)
IL (1) IL123229A (es)
NO (1) NO311567B1 (es)
NZ (1) NZ329716A (es)
PL (1) PL324768A1 (es)
SK (1) SK17698A3 (es)
TR (1) TR199800195A2 (es)
TW (1) TW450967B (es)
ZA (1) ZA981063B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6354752B1 (en) * 1995-02-09 2002-03-12 Canon Kabushiki Kaisha Printer that prints a font even when the memory is low
JP3786579B2 (ja) 1998-07-08 2006-06-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 硫黄置換スルホニルアミノカルボン酸ｎ−アリールアミド、それらの製造、それらの使用、及びそれらを含む医薬製剤
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
JP2009026126A (ja) * 2007-07-20 2009-02-05 Nec Electronics Corp 半導体装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57183751A (en) * 1981-03-12 1982-11-12 Bayer Ag Tetrachlorophthalamic acids, manufacture and use as bactericide
IL93610A0 (en) * 1989-03-08 1990-12-23 Merck Sharp & Dohme Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them
NZ276577A (en) * 1993-11-29 1997-11-24 Merrell Pharma Inc 2-acyl-4-benzenesulphonyliminoquinoline and -chromene derivatives
EP0807629B1 (de) * 1996-05-15 2004-03-03 Aventis Pharma Deutschland GmbH Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
AU727216B2 (en) 2000-12-07
NO980564L (no) 1998-08-12
SK17698A3 (en) 1998-09-09
PL324768A1 (en) 1998-08-17
NZ329716A (en) 2000-01-28
CN1193012A (zh) 1998-09-16
NO311567B1 (no) 2001-12-10
EP0857724A1 (de) 1998-08-12
BR9800596A (pt) 1999-07-20
TR199800195A2 (xx) 1998-09-21
MX9801121A (es) 1998-08-30
TW450967B (en) 2001-08-21
CA2227930A1 (en) 1998-08-11
ID21266A (id) 1999-05-12
HUP9800277A3 (en) 2000-01-28
IL123229A0 (en) 1998-09-24
HU9800277D0 (en) 1998-04-28
HRP980066B1 (en) 2002-06-30
CZ38598A3 (cs) 1998-08-12
KR19980071212A (ko) 1998-10-26
JPH10218855A (ja) 1998-08-18
IL123229A (en) 2002-04-21
HUP9800277A2 (hu) 1999-06-28
HRP980066A2 (en) 1998-10-31
DE19705133A1 (de) 1998-08-13
ZA981063B (en) 1998-08-11
NO980564D0 (no) 1998-02-10
AU5386098A (en) 1998-08-13
US6087399A (en) 2000-07-11

Similar Documents

Publication Publication Date Title
AR007115A1 (es) Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo para la preparacion de medicamento o agente de diagnostico, asi como medicamento que los contiene
BR0210374A (pt) Amidas de ácido antranìlico com cadeia lateral de heteroarilsulfonila, processos para produção das mesmas, uso das mesmas como medicamento ou agente de diagnóstico, bem como preparações farmacêuticas que contêm as mesmas
AR031430A1 (es) Compuestos de bisarilo orto, meta-sustituidos, procedimientos para su preparacion, su utilizacion como medicamento como tambien los preparados farmaceuticos que los contienen
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ATE71293T1 (de) Arzneiformulierung.
ES2058291T3 (es) Derivados de piperazinilo de las purinas e isosteros de las mismas como agentes hipoglucemicos.
MEP60908A (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
ATE289805T1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
AR011115A1 (es) Compuestos sustituidos con sulfonamida, empleos para la preparacion de un medicamento y agente curativo
AR010587A1 (es) 3-amido-cromanisulfonil(tio)ureas, procedimiento para su preparacion, su empleo y preparados farmaceuticos que las contienen
ES2090875T3 (es) Tratamiento de enfermedades inflamatorias del intestino.
BR9803367A (pt) Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos
ATE152350T1 (de) Pharmazeutische zusammensetzungen die 5- difluormethoxy-2-(3,4-dimethoxy-2- pyridyl)methylsulfinyl>-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
GR3032224T3 (en) Therapeutic agent for threatened abortion.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
WILSON Secondary suture of war wounds a clinical study of 305 secondary closures
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
SE9001308D0 (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
ES2175582T3 (es) Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su utilizacion como medicamento, asi como preparados farmaceuticos que los contienen.
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
ES2158383T3 (es) Guanididas de acidos tiofenil-alquenil-carboxilicos sustituidos, procedimiento para su preparacion, su utilizacion como medicamento o agente diagnostico, asi como medicamento que las contiene.
ES2155223T3 (es) 1-naftoilguanidinas sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene.
ES2148268T3 (es) Composicion farmaceutica para prevenir o tratar fracturas de huesos.
CN108191888A (zh) 一种用于皮肤溃疡护理的1,4-硫氮杂卓类药物化合物及其制备方法和应用